Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
- PMID: 9659534
- DOI: 10.1016/s0954-6111(98)90515-7
Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease
Abstract
C-reactive protein (CRP) has been shown to be a useful and sensitive indicator of pyogenic infections in many clinical situations, including acute pneumonia and infective pulmonary exacerbations in cystic fibrosis patients. Exacerbations of COPD are often, but not always, associated with demonstrable infection. The value of CRP measurement in this situation has not been assessed. We have evaluated CRP measurement in 50 patients [age 71 +/- 8 (SD) years] who were admitted to hospital with clinical evidence of exacerbation [PaO2 = 7.3 +/- 1.3 (SD) kPa, baseline FEV1 = 0.8 +/- 0.4 (SD) l]. These patients all had serial measurement of CRP [polarizing immunofluorescence (Abbot, TDx)], peripheral white cell count (WCC), body temperature, peak expiratory flow rate, Karnofsky performance status and chest X-ray, in addition to serial sputum bacteriological analysis carried out in a specialized laboratory. CRP was elevated (> 10 mg l-1) in all patients (n = 29) with proven infection [103 +/- 98 (SD) mg l-1]. Levels were markedly elevated in patients infected with Streptococcus pneumoniae (mean 156 mg l-1); there was also a rapid fall in the CRP with therapy. WCC fell with therapy, giving a correlation with CRP level (r = 0.44, P < 0.01). Since CRP elevation was observed in patients having exacerbation with proven infections and also in those where infection was not proven, it is possible that, while it is a marker for COPD exacerbation, it is not necessarily a marker of bacterial infection per se. However, it is evident from our study that it is of value in the assessment of exacerbations of COPD, where routine bacterial culture of sputum is often unreliable, and thus the measurement of serum CRP may provide an additional objective indicator of infection.
Similar articles
-
C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.Int J Chron Obstruct Pulmon Dis. 2016 Oct 21;11:2633-2640. doi: 10.2147/COPD.S117129. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27799762 Free PMC article.
-
Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.Wien Klin Wochenschr. 2015 Oct;127(19-20):756-63. doi: 10.1007/s00508-014-0690-6. Epub 2015 Jan 14. Wien Klin Wochenschr. 2015. PMID: 25586444
-
Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:767-74. doi: 10.2147/COPD.S76740. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25926728 Free PMC article.
-
C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.Curr Opin Pulm Med. 2009 Mar;15(2):120-5. doi: 10.1097/MCP.0b013e3283218603. Curr Opin Pulm Med. 2009. PMID: 19532026 Review.
-
The C-reactive protein.J Emerg Med. 1999 Nov-Dec;17(6):1019-25. doi: 10.1016/s0736-4679(99)00135-3. J Emerg Med. 1999. PMID: 10595891 Review.
Cited by
-
Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.Int J Chron Obstruct Pulmon Dis. 2020 Sep 30;15:2379-2388. doi: 10.2147/COPD.S266844. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33061355 Free PMC article.
-
Evaluation of plasma leptin, tumor necrosis factor-α, and prealbumin as prognostic biomarkers during clinical recovery from acute exacerbations of chronic obstructive pulmonary disease.Lung India. 2017 Jan-Feb;34(1):3-8. doi: 10.4103/0970-2113.197101. Lung India. 2017. PMID: 28144052 Free PMC article.
-
Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2018 Aug;15(8):935-946. doi: 10.1513/AnnalsATS.201710-815OC. Ann Am Thorac Soc. 2018. PMID: 29723057 Free PMC article.
-
Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial.BMC Infect Dis. 2021 Sep 29;21(1):1019. doi: 10.1186/s12879-021-06687-3. BMC Infect Dis. 2021. PMID: 34587911 Free PMC article. Clinical Trial.
-
Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease.Physiol Rep. 2014 Jul 3;2(7):e12069. doi: 10.14814/phy2.12069. Print 2014 Jul 1. Physiol Rep. 2014. PMID: 24994897 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous